Zosano Pharma Corporation (ZSAN) .
本页证实的标准:
SharesGrow 综合评分： 34/100 其中 2/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2012 | $6.98 | $11.62M | $1.82M | 15.6% |
| 2013 | $-21.52 | $4.25M | $-5.61M | -132% |
| 2014 | $-24.52 | $2.86M | $-14.24M | -497.8% |
| 2015 | $-49.81 | $313K | $-28.43M | -9082.1% |
| 2016 | $-43.32 | $0.00 | $-29.83M | - |
| 2017 | $-16.82 | $0.00 | $-29.11M | - |
| 2018 | $-3.74 | $0.00 | $-35.36M | - |
| 2019 | $-2.29 | $0.00 | $-37.59M | - |
| 2020 | $-0.49 | $224K | $-33.37M | -14896.9% |
| 2021 | $-0.27 | $785K | $-30.11M | -3836.2% |
